Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Authorised
- DL-ALPHA TOCOPHEROL ACETATE
- COLECALCIFEROL CONCENTRATE (OILY FORM)
- Retinol palmitate
Product identification
Medicine name:
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
BELAVIT AD3E SOLUTION INJECTABLE POUR CHEVAUX BOVINS PORCS ET CHIENS
Active substance:
- DL-ALPHA TOCOPHEROL ACETATE
- COLECALCIFEROL CONCENTRATE (OILY FORM)
- Retinol palmitate
Target species:
-
Cattle
-
Dog
-
Horse
-
Pig
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
DL-ALPHA TOCOPHEROL ACETATE50.00milligram(s)1.00millilitre(s)
-
COLECALCIFEROL CONCENTRATE (OILY FORM)100.00milligram(s)1.00millilitre(s)
-
Retinol palmitate176.46milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Milk120hour
-
Meat and offal259day
-
- Dog
- Horse
-
Meat and offal250day
-
Milkno withdrawal periodNot authorised for use in horses producing milk for human consumption.
-
- Pig
-
Meat and offal194day
-
-
Intramuscular use
- Cattle
-
Milk120hour
-
Meat and offal259day
-
- Dog
- Horse
-
Meat and offal250day
-
Milkno withdrawal periodNot authorised for use in horses producing milk for human consumption.
-
- Pig
-
Meat and offal194day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA11JA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- (ID3): 1 unspecified outer container with 12 Bottle (Glass) with 100 millilitre(s) (1200 millilitre(s))
- (ID2): 1 unspecified outer container with 6 Bottle (Glass) with 100 millilitre(s) (600 millilitre(s))
- (ID1): 1 unspecified outer container with 1 Bottle (Glass) with 100 millilitre(s) (100 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/0021720 2/2019
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0313/001
Concerned member states:
-
Austria
-
Croatia
-
Cyprus
-
France
-
Greece
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Norway
-
Portugal
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 15/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?: